Integra Biosciences launches $10.000 Future Lab Grant competition to modernise laboratory workflows
INTEGRA Biosciences has announced a competitive grant programme offering laboratories the opportunity to win $10,000 worth of pipetting and automation equipment to address operational challenges and enhance experimental efficiency.
Addressing operational bottlenecks in contemporary laboratories
The Future Lab Grant initiative enables one winning laboratory to collaborate with INTEGRA in designing a customised workflow solution using the company’s portfolio of liquid handling technologies. Eligible equipment spans from ergonomic electronic pipettes and compact 96-channel plate fillers to scalable automation platforms engineered for precision and throughput expansion. The programme extends recognition beyond the primary award, with the top 10 finalists each receiving personalised product recommendation kits and exclusive discounts to support laboratory objectives in 2026.
Application process and selection criteria
Laboratories may enter by completing INTEGRA’s questionnaire, which requires participants to identify their most significant operational challenge and articulate how the company’s technology would provide a solution. The application deadline is 31st December 2025, with the winner to be announced in January 2026.
The prize value excludes consumables, focusing investment on capital equipment that can deliver sustained workflow improvements.
INTEGRA Biosciences maintains engineering and production facilities in Zizers, Switzerland, and Hudson, New Hampshire, USA.
The company holds ISO 9001 certification and supplies liquid handling solutions to research, diagnostic, and quality control laboratories within the life sciences and medical sectors.
For more information, visit: https://shorturl.at/6XTg0
